期刊文献+

坦洛新联合热淋清治疗经尿道钬激光前列腺剜除术术后膀胱刺激征的疗效分析 被引量:3

Therapeutic Effect of Tamsulosin Combined with Hot Shower on Bladder Irritation after Transurethral Holmium Laser Enucleation
下载PDF
导出
摘要 目的评价坦洛新联合热淋清治疗经尿道钬激光前列腺剜除术(HOLEP)术后膀胱刺激征的疗效。方法该院泌尿外科2017年9月—2018年3月70例BPH患者纳入该研究,患者被随机分为试验组和对照组。于术后6、12、24、48和72 h分别记录膀胱刺激症状评分。结果膀胱刺激症状的发生率从77.10%(对照组)下降到65.70%(试验组)(χ^2=1.948);各个观测时间点,前6 h差异无统计学意义(Z=-0.975,P=0.329),自6 h后对照组膀胱刺激症状的严重性均高于试验组(12 h,Z=-2.590,P=0.010;24 h,Z=-2.167,P=0.030;48 h,Z=-2.956,P=0.003;72 h,Z=-2.347,P=0.015)。结论坦洛新联合热淋清可有效改善经尿道钬激光前列腺剜除术后膀胱刺激症状。 Objective To evaluate the efficacy of tamsulosin combined with thermal showers in the treatment of bladder irritation after transurethral holmium laser enucleation(HOLEP).MethodsFrom September 2017 to March 2018,70 patients with BPH were enrolled in the study.The patients were randomly divided into the experimental group and the control group.Bladder irritation symptom scores were recorded at 6,12,24,48,and 72 h after surgery.Results The incidence of bladder irritation decreased from 77.10%(control group)to 65.7%(test group)(χ^2=1.948);there was no significant difference in the first 6 h at each observation time point(Z=-0.975,P=0.329).The severity of bladder irritation in the control group was higher than that in the experimental group after 6 h(12 h,Z=-2.590,P=0.010;24 h,Z=-2.167,P=0.030;48 h,Z=-2.956,P=0.003;72 h,Z=-2.347,P=0.015).Conclusion Tamsulosin combined with hot shower clearing can effectively improve bladder irritation after transurethral holmium laser ablation.
作者 张亮 莫乃新 吕忠 王旭刚 史红雷 吴斌 ZHANG Liang;MO Nai-xin;LYU Zhong;WANG Xu-gang;SHI Hong-lei;WU Bin(Department of Urology,Wujin Hospital,Jiangsu University,Changzhou,Jiangsu Province,213002 China)
出处 《系统医学》 2019年第21期109-111,共3页 Systems Medicine
基金 2016常州市武进区科技发展计划(WS201615)
关键词 坦洛新 热淋清 经尿道前列腺钬激光剜除术 手术后并发症 膀胱刺激症状 Tamsulosin Hot drenching Transurethral resection of the prostate laser Postoperative complications Bladder irritation
  • 相关文献

参考文献15

二级参考文献113

  • 1蒋袁磊,顾自强,张俭樽,曹仁和,沈国兵,解吕中,盛烨华,陈峰,施庆岳.自拟清热止血汤剂对前列腺电切术后患者生活质量的影响[J].中国临床康复,2005,9(6):154-155. 被引量:4
  • 2陈军,徐祗顺,刘玉强,史本康,王金.两种良性前列腺增生症手术安全性和疗效的比较[J].中国激光医学杂志,2005,14(6):366-369. 被引量:2
  • 3Furuse H,Ozono S.Transurethral resection of the bladder tumor (TURBT) for non-muscle invasive bladder cancer: basic skills[J].Int J Urol,2010,17:698-699.
  • 4Bala I,Bharti N,Chaubey V K,Mandal A K.Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor[J].Urology,2012,79:853-857.
  • 5Chapple C R,Cardozo L,Steers W D,Govier F E.Solifenacin significantly improves all symptoms of overactive bladder syndrome[J].Int J Clin Pract,2006,60:959-966.
  • 6Chapple C R,Martinez-Garcia R, Selvaggi L,Toozs-Hobson P, Warnack W, Drogendijk T, et al.A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial[J].Eur Urol,2005,48:464-470.
  • 7Basra R, Kelleher C. A review of solifenacin in the treatment of urinary incontinence[J]. Ther Clin Risk Manag,2008,4:117-128.
  • 8Agarwal A, Raza M, Singhal V, Dhiraaj S,Kapoor R,Srivastava A,et al. The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study[J].Anesth Analg,2005,101:1065-1067.
  • 9Alan J W, Louis R K, Andrew C N, Alan W P, Craig A P. Campbell-Walsh Urology[M]. 9th ed. Philadelphia: Elsevier Inc,2007:9832.
  • 10Ohtake A, Ukai M, Hatanaka T, Kobayashi S, Ikeda K, Sato S, et al. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats[J].Eur J Pharmacol,2004,492:243-250.

共引文献123

同被引文献32

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部